Key terms
About ATNF
180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palo Alto, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest ATNF news
Mar 11
7:12am ET
180 Life Sciences Board Reshuffle and Strategic Refocus
Feb 29
8:14am ET
180 Life Sciences Appoints Blair Jordan as Board Director
Feb 27
7:50pm ET
180 Life Sciences trading halted, news pending
Feb 26
7:24am ET
180 Life Sciences announces 1-for-19 reverse stock split
Feb 20
8:13am ET
180 Life Sciences Wins Interim Legal Cost Coverage Ruling
Feb 16
4:37pm ET
180 Life Sciences Stockholders Endorse Strategic Financial Moves
No recent news articles are available for ATNF
No recent press releases are available for ATNF
ATNF Financials
Key terms
Ad Feedback
ATNF Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ATNF Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range